Skip to main content


October 27, 2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, recently joined 9-year-old Eleanor Barrett, a fourth-grader from Madison, Wisconsin, for a podcast on understanding and managing anxiety and nervousness. 
October 26, 2020
In this video, psychiatrist Birgit Amann, MD, discusses the common myth that stimulants are a good treatment option for all patients with attention-deficit/hyperactivity disorder (ADHD).
October 22, 2020
In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.
October 22, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).
October 21, 2020
In this video, Joohi Jimenez‑Shahed, MD, explains a 3-year, open-label study which evaluated the long-term efficacy and safety of deutetrabenazine, a treatment for the movement disorder tardive dyskinesia. 
October 21, 2020
After 25 years as CEO of Caron Treatment Centers, Doug Tieman announced recently that he plans to retire in June 2021. As he sketches out his next chapter, Tieman joins the BHE Podcast to share thoughts on how his own recovery has shaped his leadership style and management at Caron, why not-for-profits have to balance their mission with their margins, the evolution of measuring treatment outcomes…
October 20, 2020
In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.
October 20, 2020
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
October 19, 2020
Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).
October 13, 2020
In this video, neuropsychiatrist Theresa Cerulli, MD, addresses the myth that most cases of attention-deficit/hyperactivity disorder (ADHD) are simple to treat.
Back to Top